US1944530A
(en)
*
|
1929-04-08 |
1934-01-23 |
Ig Farbenindustrie Ag |
Phosphoric acid esters
|
CA777769A
(en)
*
|
1963-03-18 |
1968-02-06 |
H. Roy Clarence |
Substituted methylene diphosphonic acid compounds and detergent compositions
|
DE1248654B
(de)
*
|
1964-11-11 |
1967-08-31 |
Albright & Wilson (Mf g) Limited, Oldbury, Warwickshire (Großbritannien) |
Verfahren zur Herstellung von Phosphonsäuren und deren Salzen
|
DE2009341C3
(de)
|
1970-02-27 |
1979-06-21 |
Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen |
3-Octadecyloxy-propanol-(l)-phosphorsäure-monocholinester und Verfahren zu dessen Herstellung
|
DE2943498C2
(de)
*
|
1979-10-27 |
1983-01-27 |
Henkel KGaA, 4000 Düsseldorf |
Verfahren zur Herstellung von 3-Amino-1-hydroxypropan-1,1-diphosphonsäure
|
US4444766A
(en)
*
|
1980-10-21 |
1984-04-24 |
Boehringer Mannheim Gmbh |
Sulfur-containing phospholipid compounds and therapeutic compositions
|
CS220713B1
(cs)
|
1981-06-02 |
1983-04-29 |
Antonin Holy |
Dialkylestery kyseliny p-toluensulfonyloxymethanfosfonové a způsob jejich přípravy
|
EP0088046B1
(de)
*
|
1982-02-17 |
1987-12-09 |
Ciba-Geigy Ag |
Lipide in wässriger Phase
|
US4562179A
(en)
|
1982-04-19 |
1985-12-31 |
Fujisawa Pharmaceutical Co., Ltd. |
Phospholipid derivatives, and pharmaceutical composition of the same
|
US5047533A
(en)
*
|
1983-05-24 |
1991-09-10 |
Sri International |
Acyclic purine phosphonate nucleotide analogs
|
IT1196315B
(it)
*
|
1984-10-29 |
1988-11-16 |
Gentili Ist Spa |
Procedimento per la preparazione di acidi difosfonici
|
IL77243A
(en)
|
1984-12-21 |
1996-11-14 |
Procter & Gamble |
Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds
|
JPS61152694A
(ja)
|
1984-12-27 |
1986-07-11 |
Toyama Chem Co Ltd |
新規な5−フルオロ−2′−デオキシウリジン−5′−ホスフエ−ト誘導体およびその塩
|
US6448392B1
(en)
*
|
1985-03-06 |
2002-09-10 |
Chimerix, Inc. |
Lipid derivatives of antiviral nucleosides: liposomal incorporation and method of use
|
US5223263A
(en)
*
|
1988-07-07 |
1993-06-29 |
Vical, Inc. |
Liponucleotide-containing liposomes
|
GB8530603D0
(en)
*
|
1985-12-12 |
1986-01-22 |
Leo Pharm Prod Ltd |
Chemical compounds
|
DE3623397A1
(de)
*
|
1986-07-11 |
1988-01-14 |
Boehringer Mannheim Gmbh |
Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
|
CS264222B1
(en)
|
1986-07-18 |
1989-06-13 |
Holy Antonin |
N-phosphonylmethoxyalkylderivatives of bases of pytimidine and purine and method of use them
|
US5650510A
(en)
*
|
1986-11-18 |
1997-07-22 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Antiviral phosphonomethoxyalkylene purine and pyrimidine derivatives
|
US5247085A
(en)
*
|
1987-11-30 |
1993-09-21 |
Beecham Group P.L.C. |
Antiviral purine compounds
|
SU1548182A1
(ru)
*
|
1987-12-29 |
1990-03-07 |
Институт молекулярной биологии АН СССР |
5 @ -Фосфонаты 3 @ -азидо-2 @ ,3 @ -дидезоксинуклеозидов, вл ющиес специфическими ингибиторами вируса СПИД в культуре лимфоцитов человека Н9/ШВ
|
US6252060B1
(en)
*
|
1988-07-07 |
2001-06-26 |
Nexstar Pharmaceuticals, Inc. |
Antiviral liponucleosides: treatment of hepatitis B
|
US5817638A
(en)
*
|
1988-07-07 |
1998-10-06 |
Nexstar Pharmaceuticals, Inc. |
Antiviral liponucleosides: treatment of hepatitis B
|
CA2001401A1
(en)
*
|
1988-10-25 |
1990-04-25 |
Claude Piantadosi |
Quaternary amine containing ether or ester lipid derivatives and therapeutic compositions
|
US5411947A
(en)
*
|
1989-06-28 |
1995-05-02 |
Vestar, Inc. |
Method of converting a drug to an orally available form by covalently bonding a lipid to the drug
|
US5194654A
(en)
*
|
1989-11-22 |
1993-03-16 |
Vical, Inc. |
Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
|
IL91362A0
(en)
*
|
1989-08-20 |
1990-03-19 |
Yissum Res Dev Co |
Bisphosphonates,process for preparing them and pharmaceutical compositions containing them
|
US5196409A
(en)
*
|
1989-08-20 |
1993-03-23 |
Yissum, Research Development Company Of The Hebrew University Of Jerusalem |
Bisphosphonates, pharmaceutical compositions, and process for the treatment of irregularities in calcium metabolism
|
IT1241674B
(it)
*
|
1989-10-12 |
1994-01-27 |
Boehringer Biochemia Srl |
Acidi gem-difosfonici, un processo per la loro preparazione e composizioni farmaceutiche che li contengono.
|
DE3934820A1
(de)
|
1989-10-19 |
1991-04-25 |
Boehringer Mannheim Gmbh |
Verwendung von lecithin-analoga als antivirale arzneimittel und neue derivate
|
US5463092A
(en)
*
|
1989-11-22 |
1995-10-31 |
Vestar, Inc. |
Lipid derivatives of phosphonacids for liposomal incorporation and method of use
|
DE3942933A1
(de)
|
1989-12-23 |
1991-06-27 |
Boehringer Mannheim Gmbh |
Verwendung von alkylphospholipiden als antivirale arzneimittel und neue phospholipid-derivate
|
US6642245B1
(en)
|
1990-02-01 |
2003-11-04 |
Emory University |
Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
|
CA2083961A1
(en)
*
|
1990-05-29 |
1991-11-30 |
Henk Van Den Bosch |
Synthesis of glycerol di- and triphosphate derivatives
|
WO1992002511A1
(en)
|
1990-08-10 |
1992-02-20 |
Bristol-Myers Squibb Company |
Novel process for the preparation of nucleotides
|
DE4026265A1
(de)
*
|
1990-08-20 |
1992-02-27 |
Boehringer Mannheim Gmbh |
Neue phospholipid-derivate von nucleosiden, deren herstellung sowie deren verwendung als antivirale arzneimittel
|
ES2118069T3
(es)
*
|
1990-09-14 |
1998-09-16 |
Acad Of Science Czech Republic |
Profarmacos de fosfonatos.
|
FI89365C
(fi)
*
|
1990-12-20 |
1993-09-27 |
Leiras Oy |
Foerfarande foer framstaellning av nya farmakologiskt anvaendbara metylenbisfosfonsyraderivat
|
US5183815A
(en)
*
|
1991-01-22 |
1993-02-02 |
Merck & Co., Inc. |
Bone acting agents
|
US5672697A
(en)
*
|
1991-02-08 |
1997-09-30 |
Gilead Sciences, Inc. |
Nucleoside 5'-methylene phosphonates
|
US5300687A
(en)
*
|
1991-07-18 |
1994-04-05 |
Ortho Pharmaceutical Corporation |
Trifluoromethylbenzylphosphonates useful in treating osteoporosis
|
US5879700A
(en)
|
1991-10-15 |
1999-03-09 |
Hostetler; Karl Y. |
Nucleoside analogue phosphates for topical use
|
JP3141053B2
(ja)
*
|
1991-12-26 |
2001-03-05 |
アベンティス ファーマ株式会社 |
ビスホスホン酸誘導体
|
WO1993024500A1
(en)
*
|
1992-05-29 |
1993-12-09 |
The Procter & Gamble Pharmaceuticals, Inc. |
Thio-substituted nitrogen-containing heterocyclic phosphonate compounds for treating abnormal calcium and phosphate metabolism
|
US5665720A
(en)
|
1992-08-07 |
1997-09-09 |
Merck & Co., Inc. |
Benzoxazinones as inhibitors of HIV reverse transcriptase
|
DE59309360D1
(de)
*
|
1992-12-02 |
1999-03-18 |
Hoechst Ag |
Guanidinalkyl-1, 1-bisphosphonsäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung
|
US5512671A
(en)
*
|
1993-02-16 |
1996-04-30 |
Wake Forest University |
Ether lipid-nucleoside covalent conjugates
|
US5484911A
(en)
*
|
1993-04-01 |
1996-01-16 |
Health Research, Inc. |
Nucleoside 5'-diphosphate conjugates of ether lipids
|
US5817647A
(en)
*
|
1993-04-01 |
1998-10-06 |
Merrell Pharmaceuticals Inc. |
Unsaturated acetylene phosphonate derivatives of purines
|
AU7044894A
(en)
*
|
1993-06-10 |
1995-01-03 |
University Of North Carolina At Chapel Hill, The |
(phospho)lipids for combatting hepatitis b virus infection
|
EP0632048B1
(en)
|
1993-06-29 |
2001-03-21 |
Mitsubishi Chemical Corporation |
Phosphonate-nucleotide ester derivatives
|
US5656745A
(en)
*
|
1993-09-17 |
1997-08-12 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
US5798340A
(en)
*
|
1993-09-17 |
1998-08-25 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
EP0719274A1
(en)
*
|
1993-09-17 |
1996-07-03 |
Gilead Sciences, Inc. |
Method for dosing therapeutic compounds
|
US5567592A
(en)
|
1994-02-02 |
1996-10-22 |
Regents Of The University Of California |
Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal
|
AU704591B2
(en)
*
|
1994-04-04 |
1999-04-29 |
William R. Freeman |
Use of phosphonylmethoxyalkyl nucleosides for the treatment of raised intraocular pressure
|
ATE328890T1
(de)
*
|
1994-07-15 |
2006-06-15 |
Univ Iowa Res Found |
Immunomodulatorische oligonukleotide
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US6239116B1
(en)
*
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
WO1996006620A2
(en)
*
|
1994-08-29 |
1996-03-07 |
Wake Forest University |
Lipid analogs for treating viral infections
|
US7135584B2
(en)
|
1995-08-07 |
2006-11-14 |
Wake Forest University |
Lipid analogs for treating viral infections
|
US5696277A
(en)
|
1994-11-15 |
1997-12-09 |
Karl Y. Hostetler |
Antiviral prodrugs
|
US5627185A
(en)
*
|
1994-11-23 |
1997-05-06 |
Gosselin; Gilles |
Acyclovir derivatives as antiviral agents
|
US5977061A
(en)
|
1995-04-21 |
1999-11-02 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
N6 - substituted nucleotide analagues and their use
|
EP0753523A1
(en)
|
1995-07-10 |
1997-01-15 |
Gador S.A. |
Amino-substituted bisphosphonic acids
|
US5885973A
(en)
*
|
1995-12-27 |
1999-03-23 |
Gador, S.A. |
Bone mass anabolic composition comprising olpadronate
|
US5717095A
(en)
*
|
1995-12-29 |
1998-02-10 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
TW369536B
(en)
*
|
1996-01-18 |
1999-09-11 |
Mitsubishi Chem Corp |
Phosphonate nucleotide compounds
|
FR2746801B1
(fr)
|
1996-03-27 |
1998-05-07 |
Ceca Sa |
Esters phosphoriques d'alkyl ou d'acyl dianhydro-1,4:3,6-d- glucitol, procede de preparation et utilisations
|
US5877166A
(en)
*
|
1996-04-29 |
1999-03-02 |
Sri International |
Enantiomerically pure 2-aminopurine phosphonate nucleotide analogs as antiviral agents
|
US5922695A
(en)
*
|
1996-07-26 |
1999-07-13 |
Gilead Sciences, Inc. |
Antiviral phosphonomethyoxy nucleotide analogs having increased oral bioavarilability
|
US5760013A
(en)
*
|
1996-08-21 |
1998-06-02 |
National Science Council |
Thymidylate analogs and the use thereof
|
WO1998026749A1
(fr)
|
1996-12-19 |
1998-06-25 |
Kao Corporation |
Composition de revetement pour les dents
|
US6818629B2
(en)
|
1997-02-10 |
2004-11-16 |
Inspire Pharmaceuticals, Inc. |
Pharmaceutical formulation comprising P1-(2'-deoxycytidine 5'-)P4-(uridine 5'-) tetraphosphate
|
US6686462B2
(en)
|
1997-02-28 |
2004-02-03 |
The Regents Of The University Of California |
Antiviral compounds and methods of administration
|
US6589940B1
(en)
*
|
1997-06-06 |
2003-07-08 |
Dynavax Technologies Corporation |
Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
|
JP4280309B2
(ja)
*
|
1997-06-06 |
2009-06-17 |
ザ リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア |
Dna免疫刺激配列活性の阻害剤
|
US5935946A
(en)
*
|
1997-07-25 |
1999-08-10 |
Gilead Sciences, Inc. |
Nucleotide analog composition and synthesis method
|
WO1999009139A1
(en)
*
|
1997-08-15 |
1999-02-25 |
Rubicon Laboratory, Inc. |
Retrovirus and viral vectors
|
WO1999008685A1
(en)
|
1997-08-18 |
1999-02-25 |
Queen's University At Kingston |
Phosphono-carboxylate compounds for treating amyloidosis
|
DE69935507T2
(de)
*
|
1998-04-03 |
2007-12-06 |
University Of Iowa Research Foundation |
Verfahren und produkte zur stimulierung des immunsystems mittels immunotherapeutischer oligonukleotide und zytokine
|
WO1999062513A1
(en)
|
1998-06-03 |
1999-12-09 |
Merck & Co., Inc. |
Hiv integrase inhibitors
|
CA2333707A1
(en)
|
1998-06-03 |
1999-12-09 |
Melissa Egbertson |
Hiv integrase inhibitors
|
US6562798B1
(en)
*
|
1998-06-05 |
2003-05-13 |
Dynavax Technologies Corp. |
Immunostimulatory oligonucleotides with modified bases and methods of use thereof
|
FR2781228B1
(fr)
|
1998-07-16 |
2000-09-29 |
Pf Medicament |
Phosphonates insatures derives d'indole
|
CA2333854A1
(en)
|
1998-07-27 |
2000-02-10 |
University Of Iowa Research Foundation |
Stereoisomers of cpg oligonucleotides and related methods
|
CA2344558A1
(en)
|
1998-10-09 |
2000-04-20 |
Dynavax Technologies Corporation |
Anti hiv compositions comprising immunostimulatory polynucleotides and hiv antigens
|
WO2000036132A1
(en)
|
1998-12-14 |
2000-06-22 |
Merck & Co., Inc. |
Hiv integrase inhibitors
|
DE19859426A1
(de)
|
1998-12-22 |
2000-07-06 |
Hassan Jomaa |
Verwendung von phosphororganischen Verbindungen zur therapeutischen und prophylaktischen Behandlung von Infektionen
|
DE69939749D1
(de)
|
1998-12-25 |
2008-11-27 |
Shionogi & Co |
Aromatische heterocyclen mit hiv integrase inhibierenden eigenschaften
|
CA2376043A1
(en)
|
1999-06-02 |
2000-12-14 |
Shionogi & Co., Ltd. |
Novel processes for the preparation of substituted propenone derivatives
|
JP2003503386A
(ja)
|
1999-06-25 |
2003-01-28 |
メルク エンド カムパニー インコーポレーテッド |
1−(芳香族またはヘテロ芳香族置換)−3−(ヘテロ芳香族置換)−1,3−プロパンジオン類およびそれの使用
|
US6245806B1
(en)
|
1999-08-03 |
2001-06-12 |
Merck & Co., Inc. |
HIV integrase inhibitors
|
CA2380947C
(en)
|
1999-08-19 |
2011-11-01 |
Dynavax Technologies Corporation |
Methods of modulating an immune response using immunostimulatory sequences and compositions for use therein
|
ES2218216T3
(es)
|
1999-09-24 |
2004-11-16 |
Shire Biochem Inc. |
Analogos de nucleosidos de dioxolano para el tratamiento o la prevencion de infecciones viricas.
|
SK287400B6
(sk)
|
1999-09-25 |
2010-08-09 |
University Of Iowa Research Foundation |
Prostriedok s obsahom imunostimulačnej nukleovej kyseliny a jeho použitie na stimuláciu imunitnej reakcie
|
DE60029460T3
(de)
|
1999-09-27 |
2011-02-10 |
Coley Pharmaceutical Gmbh |
Verfahren mittels durch nukleinsäuren induziertes immunostimulatorisches interferon
|
WO2001027309A1
(en)
|
1999-10-13 |
2001-04-19 |
Merck & Co., Inc. |
Hiv integrase inhibitors
|
US6670341B1
(en)
|
1999-10-28 |
2003-12-30 |
Wake Forest University Health Sciences |
Compositions and methods for double-targeting virus infections and targeting cancer cells
|
US7026469B2
(en)
*
|
2000-10-19 |
2006-04-11 |
Wake Forest University School Of Medicine |
Compositions and methods of double-targeting virus infections and cancer cells
|
AU785355B2
(en)
|
1999-12-03 |
2007-02-01 |
Regents Of The University Of California At San Diego, The |
Phosphonate compounds
|
EP1914237B1
(en)
|
1999-12-03 |
2014-06-18 |
The Regents of The University of California |
Phosphonate ester antiviral compounds
|
EP1118333A1
(en)
|
2000-01-18 |
2001-07-25 |
Eurand International S.P.A. |
Compositions with enhanced oral bioavailability
|
WO2001054636A1
(en)
*
|
2000-01-28 |
2001-08-02 |
Board Of Regents, The University Of Texas System |
Methods and devices for preventing transmission of sexually transmitted diseases
|
US20020136757A1
(en)
*
|
2000-01-28 |
2002-09-26 |
Samuel Baron |
Methods and devices for preventing transmission of sexually transmitted diseases
|
ES2627903T3
(es)
*
|
2000-07-21 |
2017-08-01 |
Gilead Sciences, Inc. |
Profármacos de análogos de nucleótidos de fosfonato y métodos para seleccionar y preparar los mismos
|
ES2287170T3
(es)
|
2000-10-12 |
2007-12-16 |
MERCK & CO., INC. |
Aza- y poliaza-naftalenil-carboxamidas utilies como inhibidores de la vih integrasa.
|
AU2002230392A1
(en)
|
2000-10-12 |
2002-05-15 |
Merck & Co., Inc. |
AZA-and polyaza-naphthalenyl ketones useful as HIV integrase inhibitors
|
WO2002030930A2
(en)
|
2000-10-12 |
2002-04-18 |
Merck & Co., Inc. |
Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
|
CA2425625A1
(en)
|
2000-10-12 |
2002-07-18 |
Merck & Co., Inc. |
Aza-and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
|
US7288265B1
(en)
*
|
2000-10-16 |
2007-10-30 |
Lectec Corporation |
Treating viral infection at smallpox vaccination site
|
US7309696B2
(en)
*
|
2000-10-19 |
2007-12-18 |
Wake Forest University |
Compositions and methods for targeting cancer cells
|
WO2002040021A2
(en)
|
2000-11-17 |
2002-05-23 |
Idenix (Cayman) Limited |
Methods for inhibiting the transmission of hiv using topically applied substituted 6-benzyl-4-oxopyrimidines
|
US6605602B1
(en)
*
|
2001-09-28 |
2003-08-12 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Method of treating BK virus nephropathy
|
WO2003030934A2
(en)
|
2001-10-06 |
2003-04-17 |
Merial Limited |
Cpg formulations and related methods
|
KR20040045882A
(ko)
|
2001-10-23 |
2004-06-02 |
오노 야꾸힝 고교 가부시키가이샤 |
트리아자스피로[5.5]운데칸 유도체와 시토크롬 p450이소자임 3a4 억제제 및/또는 p-당단백질 억제제를조합한 의약
|
US20040022873A1
(en)
*
|
2001-11-09 |
2004-02-05 |
Guilford F. Timothy |
Systemic administration of NAC as an adjunct in the treatment of bioterror exposures such as anthrax, smallpox or radiation and for vaccination prophylaxis, and use in combination with DHEA for the treatment of smallpox and other viruses
|
US20040071757A1
(en)
*
|
2001-11-20 |
2004-04-15 |
David Rolf |
Inhalation antiviral patch
|
TWI286476B
(en)
|
2001-12-12 |
2007-09-11 |
Tibotec Pharm Ltd |
Combination of cytochrome P450 dependent protease inhibitors
|
CA2474056A1
(en)
|
2002-01-24 |
2003-07-31 |
Sangstat Medical Corporation |
Combination therapy for treatment of hiv infection
|
ATE367394T1
(de)
*
|
2002-04-26 |
2007-08-15 |
Gilead Sciences Inc |
Anreicherung in der zelle an phosphonat analoga von hiv protease inhibitor verbindungen und die verbindungen selbst
|
WO2004035577A2
(en)
|
2002-10-16 |
2004-04-29 |
Gilead Sciences, Inc. |
Pre-organized tricyclic integrase inhibitor compounds
|
WO2004062600A2
(en)
|
2003-01-08 |
2004-07-29 |
Lectec Corporation |
Antiviral patch
|
KR20080032014A
(ko)
|
2003-01-14 |
2008-04-11 |
길리애드 사이언시즈, 인코포레이티드 |
복합 항바이러스 치료를 위한 조성물 및 방법
|
US20050261237A1
(en)
|
2003-04-25 |
2005-11-24 |
Boojamra Constantine G |
Nucleoside phosphonate analogs
|
KR20060006047A
(ko)
|
2003-04-28 |
2006-01-18 |
티보텍 파마슈티칼즈 리미티드 |
Hiv 인테그레이즈 저해제
|
PL1638938T3
(pl)
|
2003-06-20 |
2017-10-31 |
Siga Tech Inc |
Związki, kompozycje i sposoby do leczenia i zapobiegania infekcjom ortopokswirusami i powiązanym chorobom
|
TW200510425A
(en)
|
2003-08-13 |
2005-03-16 |
Japan Tobacco Inc |
Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor
|
WO2005090370A1
(en)
*
|
2004-02-05 |
2005-09-29 |
The Regents Of The University Of California |
Pharmacologically active agents containing esterified phosphonates and methods for use thereof
|
CN1921867B
(zh)
|
2004-02-17 |
2010-05-05 |
株式会社Lg生命科学 |
用于治疗hiv感染的膦酸核苷衍生物
|
US20050187192A1
(en)
*
|
2004-02-20 |
2005-08-25 |
Kucera Pharmaceutical Company |
Phospholipids for the treatment of infection by togaviruses, herpes viruses and coronaviruses
|
WO2005087788A2
(en)
|
2004-03-04 |
2005-09-22 |
The Regents Of The University Of California |
Methods for preparation of nucleoside phosphonate esters
|
WO2006076015A2
(en)
*
|
2004-04-30 |
2006-07-20 |
The Regents Of The University Of California |
1-[2-(phosphonomethoxy)ethyl]-cytosine and analogs thereof
|
US8541167B2
(en)
*
|
2004-06-03 |
2013-09-24 |
Saint Louis University |
Methods and compositions for vaccination
|
UA93354C2
(ru)
|
2004-07-09 |
2011-02-10 |
Гилиад Сайенсиз, Инк. |
Местный противовирусный препарат
|
EP1802287A2
(en)
*
|
2004-09-27 |
2007-07-04 |
Sigmoid Biotechnologies Limited |
Minicapsule formulations
|
ES2401285T3
(es)
|
2004-12-16 |
2013-04-18 |
The Regents Of The University Of California |
Fármacos con el pulmón como diana
|
US7250421B2
(en)
|
2005-01-31 |
2007-07-31 |
University Of Georgia Research Foundation, Inc. |
Diketo acids with nucleobase scaffolds: anti-HIV replication inhibitors targeted at HIV integrase
|
TW200714289A
(en)
|
2005-02-28 |
2007-04-16 |
Genentech Inc |
Treatment of bone disorders
|
US20090156545A1
(en)
*
|
2005-04-01 |
2009-06-18 |
Hostetler Karl Y |
Substituted Phosphate Esters of Nucleoside Phosphonates
|
EP2842559A3
(en)
|
2005-04-08 |
2015-03-18 |
Chimerix, Inc. |
Compounds, compositions and methods for the treatment of viral infections and other medical disorders
|
WO2006110655A2
(en)
|
2005-04-08 |
2006-10-19 |
Chimerix, Inc. |
Compounds, compositions and methods for the treatment of poxvirus infections
|
TW200716632A
(en)
|
2005-05-16 |
2007-05-01 |
Gilead Sciences Inc |
Integrase inhibitor compounds
|
TWI471145B
(zh)
|
2005-06-13 |
2015-02-01 |
Bristol Myers Squibb & Gilead Sciences Llc |
單一式藥學劑量型
|
US9044509B2
(en)
|
2006-02-03 |
2015-06-02 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Inhibition of HIV infection through chemoprophylaxis
|
CN100396689C
(zh)
*
|
2006-03-07 |
2008-06-25 |
中国医学科学院医药生物技术研究所 |
一组具有抑制hiv-1/hbv病毒复制活性的替诺福韦单酯化合物
|
ES2600792T3
(es)
|
2006-05-03 |
2017-02-10 |
Chimerix, Inc. |
Alcoxialquilésteres metabólicamente estables de fosfonatos, fosfonatos nucleosídicos y fosfatos nucleosídicos antivirales o antiproliferativos
|
KR101636221B1
(ko)
|
2006-07-07 |
2016-07-04 |
길리애드 사이언시즈, 인코포레이티드 |
치료제의 약동학 특성의 모듈레이터
|
WO2008007392A2
(en)
|
2006-07-12 |
2008-01-17 |
Matrix Laboratories Limited |
Process for the preparation of tenofovir
|
US20080161324A1
(en)
*
|
2006-09-14 |
2008-07-03 |
Johansen Lisa M |
Compositions and methods for treatment of viral diseases
|
DK2308514T3
(da)
|
2007-03-23 |
2013-09-02 |
To Bbb Holding B V |
Konjugater til målrettet lægemiddeltransport gennem blod-hjerne barrieren
|
WO2008133982A2
(en)
|
2007-04-27 |
2008-11-06 |
Lectec Corporation |
Adhesive patch with aversive agent
|
EP2155257B1
(en)
|
2007-04-27 |
2016-10-05 |
Chimerix, Inc. |
Methods of reducing nephrotoxicity in subjects administered with nucleoside
|
EP2160468B1
(en)
|
2007-05-21 |
2012-01-11 |
Saint Louis University |
Screening tool for antiviral agents
|
WO2008150438A1
(en)
*
|
2007-06-01 |
2008-12-11 |
Luitpold Pharmaceuticals, Inc. |
Pmea lipid conjugates
|
EP2240504A1
(en)
*
|
2008-01-03 |
2010-10-20 |
Virochem Pharma Inc. |
Novel c-21-keto lupane derivatives preparation and use thereof
|
CN101981047A
(zh)
|
2008-01-03 |
2011-02-23 |
Viro化学制药公司 |
新的羽扇烷衍生物
|
US8614200B2
(en)
|
2009-07-21 |
2013-12-24 |
Chimerix, Inc. |
Compounds, compositions and methods for treating ocular conditions
|
BR112012002551A2
(pt)
|
2009-08-03 |
2017-06-13 |
Chimerix Inc |
composição e métodos de tratamento de infecções virais e tumores induzidos por vírus
|
WO2011053812A1
(en)
|
2009-10-30 |
2011-05-05 |
Chimerix, Inc. |
Methods of treating viral associated diseases
|
EP2534150B1
(en)
*
|
2010-02-12 |
2017-04-05 |
Chimerix, Inc. |
Methods of treating viral infection
|